BAppSci, PhD, National Manager, Primary Care Collaborative Cancer Clinical Trials Group (PC4), Department of General Practice, and Centre for Cancer Research, University of Melbourne, Vic.
BSc (Hons), MSc (Epi), Clinical Trial Network Coordinator, Monash University, Melbourne, Vic.
Aust J Gen Pract. 2024 Apr;53(4):227-234. doi: 10.31128/AJGP-02-23-6699.
The Primary Care Collaborative Cancer Clinical Trials Group (PC4) is funded by Cancer Australia to support the development of new cancer in primary care research. We undertook a research prioritisation exercise to identify cancer research priorities in Australian general practice.
We adapted the nominal group technique, including a literature search and stakeholder survey. An expert group from the Primary Care Collaborative Cancer Clinical Trials Group consolidated and ranked priorities. A second stakeholder survey reviewing the top 50 priorities informed a final prioritisation workshop.
Overall, 311 priorities were identified across the cancer continuum. Nearly one-third of priorities were related to cancer survivorship and included strategies to detect recurrence, behavioural interventions and tools to assess physical and psychosocial aspects of survivorship. Prevention/early detection comprised 43.4% of priorities. Palliative care produced the least priorities (9.6%). Cross cutting research priorities (15.1%) included quality and models of care.
This is the first study to identify cancer research priorities for general practice in Australia. It could be used to inform the development of targeted research and funding to improve the care and outcomes for Australians affected by cancer.
初级保健协作癌症临床试验组（PC4）由澳大利亚癌症协会资助，旨在支持初级保健领域癌症新研究的发展。我们开展了一项研究优先级确定工作，以确定澳大利亚全科医学中的癌症研究重点。
我们采用名义群体技术，包括文献检索和利益相关者调查。来自初级保健协作癌症临床试验组的专家组对优先级进行了整合和排序。对前 50 项重点的第二次利益相关者调查为最终的重点确定研讨会提供了信息。
总体而言，在癌症连续体中确定了 311 项重点。近三分之一的重点与癌症生存有关，包括检测复发的策略、行为干预和评估生存的身体和心理社会方面的工具。预防/早期发现占重点的 43.4%。姑息治疗产生的重点最少（9.6%）。跨领域研究重点（15.1%）包括质量和护理模式。
这是第一项确定澳大利亚普通实践中癌症研究重点的研究。它可以用于为有针对性的研究和资金提供信息，以改善受癌症影响的澳大利亚人的护理和结果。
